Incidence of acute exacerbation in patients with interstitial lung disease after COVID-19 vaccination

Acute exacerbations due to COVID-19 vaccination in patients with interstitial lung disease (ILD) have been reported, but their incidence is unknown. We investigated the incidence of exacerbations of ILD and respiratory symptoms due to the mRNA COVID-19 vaccines. A questionnaire survey was conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakayori, Masashi, Hagiwara, Eri, Baba, Tomohisa, Kitamura, Hideya, Sekine, Akimasa, Ikeda, Satoshi, Tabata, Erina, Yamada, Sho, Fujimoto, Kazushi, Ogura, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2023
Materias:
Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468306/
https://www.ncbi.nlm.nih.gov/pubmed/36113847
http://dx.doi.org/10.1016/j.jiac.2022.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468306/
https://www.ncbi.nlm.nih.gov/pubmed/36113847
http://dx.doi.org/10.1016/j.jiac.2022.09.006

Ejemplares similares